In a deal worth up to $1.88 billion, Vir Biotechnology Inc. signed on to work with Gilead Sciences Inc. to discover and ...

Med-tech financings across all categories totaled $15.69 billion in the first nine months of 2026, down 33% from $23.34 ...

If you had told me when I graduated med school or left my residency that we would ever be able to treat pancreatic cancer ...

Since his May 2022 release from prison on a securities fraud conviction, Martin Shkreli has been violating a U.S. federal court order by publicly trading in biopharma stocks, engaging in public ...

Recognizing the unique challenges of developing and evaluating drugs to treat rare diseases, the U.S. FDA launched the Rare Disease Framework Initiative Oct. 14 to develop an optimized, ...

The Japanese government is seeking to strengthen the country’s global biotech position amid U.S. drug pricing changes and ...

Psychiatric drug discovery is “ready for transformation 2.0,” Roger McIntyre told his audience at the annual congress of the ...

Sitryx Therapeutics Ltd. has delivered the first clinical data for a new mechanism of action (MOA) in atopic dermatitis and ...

The activin receptor-like kinase 7 (ALK7) pathway got another vote of confidence as Rona Therapeutics Inc. came to terms with ...

Diosynvax Ltd., a spinout of the University of Cambridge, together with partners at the University of Cambridge, University ...

Two phase III successes have delivered validation for Bristol Myers Squibb Co. across two strategically important programs, ...

The Royal Swedish Academy of Sciences has awarded the 2026 Nobel Prize in Chemistry to Henri Kagan and Kenso Soai for ...